Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: A multicenter randomized clinical trial

Chinese Medical Journal

Volumn 123, Issue 11, 2010, Pages 1365-1372

  Gao, Run Lin ^a   Han, Ya Ling ^b   Yang, Xin Chun ^c   Mao, Jie Ming ^d   Fang, Wei Yi ^e   Wang, Lei ^f   Shen, Wei Feng ^g   Li, Zhan Quan ^h   Jia, Guo Liang ⁱ   Lü, Shu Zheng ^j   Wei, Meng ^k   Zeng, Ding Yin ^l   Chen, Ji Lin ^a   Qin, Xue Wen ^a   Xu, Bo ^a   Du, Chang Hui ^m  

^a FUWAI HOSPITAL   (China)

^b Shenyang Northern Hospital   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

^e DALIAN MEDICAL UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h Liaoning Provincial People's Hospital   (China)

ⁱ FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^j CAPITAL MEDICAL UNIVERSITY   (China)

^k SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^l CHINA MEDICAL UNIVERSITY   (China)

^m SICHUAN UNIVERSITY   (China)

more..

Author keywords

Acute myocardial infarction; Primary percutaneous coronary intervention; Rescue percutaneous coronary intervention; Thorombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR; RECOMBINANT STAPHYLOKINASE; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RESCUE PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 77953485585     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.11.002     Document Type: Article

References (30)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction. Lancet 2003; 365: 13-20.
2. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan GM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction; findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373-377.
3. Gao R, Patel A, Gao W, Huang D, Kong L, Qi W, et al. CPACS Investigators. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart 2008; 94: 554-560.
4. Cannon CP, Gibson CM, Mc Cabe CH, Adgev AA, Schweiger MJ, Sequeira RF, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIM 10 B trial. Circulation 1998; 98: 2805-2814.
5. Ellis SG, de Silva ER, Heyndrickx G, Talley JD, Cernig-liaro C, Steg G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction. Circulation 1994; 90: 2280-2284.
6. Ross AM, Lundergan CF, Rohrbeck SC, Boyle DN, van den Brand M, Buller CH, et al. GUSTO-1 Angiographic Investigators. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. J Am Coll Cardiol 1998; 31: 1511-1517.
7. Gibson CM, Cannon CP, Greene RM, Sequeira RF, Margorien RD, Leya F, et al. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. Am J Cardiol 1997; 80: 21-26.
8. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Hall JA, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed thrombolysis in ST-segment elevation myocardial infarction: the Middle-sbrough Early Revascularization to Limit Infarction (MERLIN) trial. J Am Coll Cardiol 2004; 44: 287-296.
9. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech FD, et al. One year results of Middlesbrough early revascularization to limit infarction (MERLIN) trial. Heart 2005; 91: 1330-1337.
10. Kunadian H, Sutton AG, Vijayalakshmi K, Thornlcy AR, Gray JC, Grech ED, et al. Early invasive versus conservative treatment in patients with failed thrombolysis-no late survival benefit: the final analysis of Middelsbrough Early Revascularization to Limit Infarction (MERLLN) trial. Am Heart J 2007; 153: 763-771.
11. Gershlick AH, Stepheus-L loyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, et al, for the REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005; 353: 2758-2868.
12. Collaborative Research Group of Reperfusion Therapy in Myocardial Infarction. A randomized multicenter trial comparing recombinant staphylokinase with recombinant tissue-type plasminogen activator in patients with acute myocardial infarction. Chin J Cardiol (Chin) 2007; 35: 691-696.
13. TIMI study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312: 932-936.
14. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Glambartolomei A, et al, for The Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949-1956.
15. Vanderschuren S, Barrios L, Kerdsinchi P, Van den Heuvel P, Hermens L, Vrolix M, et al, for the STAR Trial Group. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 1995; 92: 2044-2049.
16. Armstrong PW, Burton JR, Palisaitis D, Thompson CR, Van de Werf F, Rose B, et al. Collaborative angiographic patency trial of recombinant staphylokinase (CAPTERS). Am Heart J 2000; 139: 820-823.
17. Ross AM, Gao R, Coyne KS, Chen J, Yao K, Yang Y, et al, on behalf of TUCC Investigators. A randomized trial comparing the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am Heart J 2001; 142: 244-247.
18. Ellis SG, Da Silva ER, Spaulding CM, Nobuyoshi M, Meiner B, Talley JD. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000; 139: 1046-1053.
19. Sutton AGC, Campbell PG, Grech ED, Price DJA, Davis A, Hall JA, et al. Failure of thrombolysis: experience with policy of early angioplasty and rescue angioplasty for electrocardiographic evidence of failed thrombolysis. Heart 2000; 84: 197-204.
20. Bar FW, Ophnis TJ, Frederiks J, de Swart HB, Van OmmenVG, de Zwaan C, et al. Rescue PTCA following failed thrombolysis and primary PTCA: a retrospective study of angiographic and clinical outcome. J Thromb Thrombolysis 1997; 4: 281-288.
21. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Phillips CO, et al. Rescue angioplasty or repeat fibrinolysis after failed thrombolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. Am J Coll Cardiol 2007; 49: 422-430.
22. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline. Circulation 2008; 117: 261-295.
23. The GUSTO Angiographic Investigators. The effects of tissue-plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993, 329: 1615-1622.
24. Kammler J, Kypta A, Hoffmann R, Kerschner K, Grund M, Sihorsch K, et al. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol 2008; Epub ahead of print.
25. Silber S, Albertson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-847.
26. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142-150.
27. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Heiber U, Kazmaier S, et al. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and acteplase regimens with focus on the kallikrein system and plasmin. Circulation 1998; 98: 2527-2533.
28. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 2006; 367: 569-578.
29. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, et al. Comparison of Angioplasty and Prehospital Thromboysis in Acute Myocardial Infarction study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360: 825-829.
30. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart 2003; 24: 94-104.